© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
GEM DRUGS GRAMERCY
PO BOX 1511
June 01, 2021
How can understanding the opioid crisis in Canada inform strategies in the United States?
September 27, 2018
Symptoms of alcohol and drug intoxication and withdrawal may resemble symptoms of bipolar disorder, making it difficult to diagnose and treat.
August 04, 2017
The authors compare the clinical features of idiopathic psychosis (eg, schizophrenia) with cannabis-induced psychosis.
July 14, 2017
Numerous lines of evidence suggest a correlation between cannabis consumption and a variety of psychiatric conditions, including cannabis-induced psychosis.
December 23, 2013
This article provides an overview of research concerning referral strategies for patients with substance use disorder and co-occurring disorders in the emergency department.
December 19, 2013
Here: a succinct review of some of the potential promises and pitfalls of DSM-5.
October 15, 2013
The authors evaluate the effects of nicotine and cannabis on neurocognitive function in individuals with schizophrenia and review potential pharmacological treatment strategies.
February 13, 2013
It is clear that the prognosis for schizophrenia is much better when patients achieve drug abstinence, including in the domains of depression, quality of life, and community integration.
December 13, 2012
This article reviews the recent knowledge about glutamate in different psychiatric conditions based on research published in the past year.
September 14, 2012
Disparate means of accessing marijuana complicates the evaluation of the quality, purity, and potency of cannabis.